652982-73-5 Usage
1H-Indene-1-acetic acid derivative
This compound is a derivative of 1H-indene-1-acetic acid, which is a chemical structure that consists of a five-membered aromatic ring with a side chain.
2,3-Dihydro
The compound has two hydrogen atoms added to the 2 and 3 positions of the indene ring, which makes it a dihydro derivative.
5-Substituted
The 5 position of the indene ring is substituted with an ethyl ester group, which contains an ethoxy side chain.
Pyrazole ring
The compound contains a pyrazole ring, which is a five-membered aromatic ring with two nitrogen atoms.
Phenyl and trifluoromethyl substituents
The pyrazole ring has a phenyl group (a six-membered aromatic ring) and a trifluoromethyl group (a carbon atom with three fluorine atoms) attached to it.
Ethyl ester group
The compound has an ethyl ester group, which is a lipophilic group that can easily pass through cell membranes.
(1S) configuration
The compound is a chiral molecule with a specific arrangement of atoms around the stereocenter, which is indicated by the (1S) configuration.
Potential pharmaceutical or industrial applications
Due to its intricate structure and specific interactions with biological systems, this compound may have potential applications in the pharmaceutical or industrial industries.
Check Digit Verification of cas no
The CAS Registry Mumber 652982-73-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,5,2,9,8 and 2 respectively; the second part has 2 digits, 7 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 652982-73:
(8*6)+(7*5)+(6*2)+(5*9)+(4*8)+(3*2)+(2*7)+(1*3)=195
195 % 10 = 5
So 652982-73-5 is a valid CAS Registry Number.
652982-73-5Relevant articles and documents
INDANE, DIHYDROBENZOFURAN, AND TETRAHYDRONAPHTHALENE CARBOXYLIC ACID DERIVATIVES AND THEIR USE AS ANTIDIABETICS
-
Page 149, (2010/02/06)
This invention relates to novel indane, dihydrobenzofuran, and tetrahydronaphthalene carboxylic acid derivatives whice are useful in the treatment of diseases such sa diabetes, diabetes-related disorders, obesity, hyperlipidemia, and cardiovascular diseases. The invention also relates to intermediates useful in preparation of said carboxylic derivatives and to methods of preparation.
